12 Health Care Stocks Moving In Wednesday’s Pre-Market Session
Gainers Recursion Pharmaceuticals (NASDAQ:RXRX) stock increased by 152.1% to $17.09 during Wednesday’s pre-market session. The company’s market cap…
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
Gainers
Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on Tuesday.
Why Are Cingulate Shares Trading Higher Today?
Cingulate Inc (NASDAQ: CING) announced topline results from its Phase 3 adult trial of its lead candidate, CTx-1301 (dexmethylphenidate) for attention-deficit/
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers CytoMed Therapeutics (NASDAQ:GDTC) stock moved upwards by 153.9% to $8.86 during Tuesday’s pre-market session. The market value…
Market-Moving News for July 11th
CING: 81.5% - Cingulate Announces Positive Top-Line Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHDDFLI: 45.8% - Dragonfly Energy Partners with World's Largest Teardrop
Cingulate Successfully Manufactures Clinical Supply, Initiation Of Pediatric Phase 3 Studies To Commence In July And August
Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation
Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Airspan Networks Holdings Inc. (NYSE: MIMO) shares gained 79.5% to $0.2740.
Why PacWest Bancorp Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket
Gainers
PacWest Bancorp (NASDAQ: PACW) rose 29.9% to $12.66 in pre-market trading after multiple insider buys by Officers, Directors reported late Monday.
Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.
5 Short Squeeze Candidates To Watch: Ambrx Biopharma, Kala Pharmaceuticals And This Company That Moved Up 1,403 Positions
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move.
High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze.